Triodos Investment Management BV Has $27.15 Million Stake in Xylem Inc. (NYSE:XYL)

Triodos Investment Management BV grew its stake in Xylem Inc. (NYSE:XYL - Free Report) by 12.7% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 234,000 shares of the industrial products company's stock after acquiring an additional 26,300 shares during the period. Xylem accounts for about 2.2% of Triodos Investment Management BV's investment portfolio, making the stock its 22nd biggest position. Triodos Investment Management BV owned approximately 0.10% of Xylem worth $27,149,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds have also modified their holdings of the stock. Lee Danner & Bass Inc. bought a new position in shares of Xylem in the 4th quarter valued at about $30,000. Rialto Wealth Management LLC acquired a new position in shares of Xylem in the fourth quarter valued at approximately $31,000. Heck Capital Advisors LLC bought a new stake in shares of Xylem during the fourth quarter worth $36,000. Pathway Financial Advisers LLC lifted its position in Xylem by 122.4% in the 4th quarter. Pathway Financial Advisers LLC now owns 318 shares of the industrial products company's stock valued at $37,000 after acquiring an additional 175 shares in the last quarter. Finally, SRS Capital Advisors Inc. increased its holdings in Xylem by 69.5% during the 4th quarter. SRS Capital Advisors Inc. now owns 317 shares of the industrial products company's stock worth $37,000 after purchasing an additional 130 shares in the last quarter. 87.96% of the stock is owned by institutional investors.

Xylem Price Performance

Shares of XYL traded up $0.24 during midday trading on Tuesday, hitting $119.70. The company's stock had a trading volume of 266,001 shares, compared to its average volume of 1,309,932. The company has a quick ratio of 1.33, a current ratio of 1.76 and a debt-to-equity ratio of 0.19. Xylem Inc. has a one year low of $113.26 and a one year high of $146.08. The stock has a market capitalization of $29.09 billion, a price-to-earnings ratio of 32.81, a price-to-earnings-growth ratio of 2.33 and a beta of 1.08. The company's fifty day simple moving average is $125.69 and its two-hundred day simple moving average is $125.77.

Remove Ads

Xylem (NYSE:XYL - Get Free Report) last issued its earnings results on Tuesday, February 4th. The industrial products company reported $1.18 EPS for the quarter, topping the consensus estimate of $1.12 by $0.06. The firm had revenue of $2.30 billion during the quarter, compared to the consensus estimate of $2.18 billion. Xylem had a return on equity of 9.96% and a net margin of 10.40%. The business's quarterly revenue was up 8.6% on a year-over-year basis. During the same quarter in the previous year, the firm earned $0.99 earnings per share. As a group, equities analysts expect that Xylem Inc. will post 4.65 earnings per share for the current fiscal year.

Xylem Increases Dividend

The company also recently declared a quarterly dividend, which was paid on Wednesday, March 19th. Stockholders of record on Tuesday, February 18th were paid a dividend of $0.40 per share. This represents a $1.60 dividend on an annualized basis and a dividend yield of 1.34%. This is a positive change from Xylem's previous quarterly dividend of $0.36. The ex-dividend date was Tuesday, February 18th. Xylem's dividend payout ratio (DPR) is presently 43.72%.

Analyst Ratings Changes

Several research firms have recently weighed in on XYL. Stifel Nicolaus reduced their price objective on Xylem from $166.00 to $150.00 and set a "buy" rating for the company in a research report on Friday, January 24th. Robert W. Baird raised their price objective on Xylem from $139.00 to $148.00 and gave the company an "outperform" rating in a report on Wednesday, February 5th. Wolfe Research restated a "peer perform" rating on shares of Xylem in a research note on Thursday, December 12th. Finally, Citigroup cut shares of Xylem from a "strong-buy" rating to a "hold" rating in a research note on Wednesday, February 5th. Four investment analysts have rated the stock with a hold rating and six have issued a buy rating to the company's stock. According to MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and an average target price of $149.89.

Xylem Company Profile

Xylem Inc, together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions worldwide. It operates through four segments: Water Infrastructure, Applied Water, Measurement & Control Solutions, and Integrated Solutions and Services. The Water Infrastructure segment offers products, including water, storm water, and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment and rental services under the ADI, Flygt, Godwin, Sanitaire, Magneto, Neptune Benson, Ionpure, Leopold, Wedeco, and Xylem Vue brands.